Katarzyna Kosicka-Noworzyń

associate professor

Uniwersytet Medyczny imienia Karola Marcinkowskiego w Poznaniu

Poland

Research Interests

Explore related searches

Professors in Poland Professors in Immunology Immunology professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Katarzyna Kosicka-Noworzyń is an associate professor at Uniwersytet Medyczny im Karola Marcinkowskiego w Poznaniu, Poland. Her research focuses on pharmacokinetics, drug metabolism related to obesity, and the effects of immunotherapy in cancer treatment. Recent publications include studies on drug-metabolizing enzymes, therapeutic drug monitoring, and quantification methods for various drugs in biological matrices.

Articles (12)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2021

Collaborators (4)

Luigi Brunetti

UNITED STATES

View details

Anna Siemiątkowska

Rutgers University

UNITED STATES

View details

Marta Karaźniewicz-Łada

Poznan University of Medical Sciences

POLAND

View details

Franciszek Główka

Poznan University of Medical Sciences

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Katarzyna Kosicka-Noworzyń

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Obesity-related drug-metabolizing enzyme expression alterations in the human liver

Low serum neopterin early indicates durable benefits of atezolizumab and pembrolizumab therapy in advanced lung cancer

Pharmacokinetics of Nivolumab and Erythropoietin in a Rat Model of Diet-Induced Obesity

Bioanalytical considerations for quantification of ondansetron in rat microdialysis study using LC-MS/MS

Development and Validation of a UPLC-MS/MS Method for Therapeutic Drug Monitoring, Pharmacokinetic and Stability Studies of First-Line Antituberculosis Drugs in Urine

A validated LC-MS/MS method for simultaneous quantitation of piperacillin, cefazolin, and cefoxitin in rat plasma and twelve tissues

Obesity-related drug transporter expression alterations in human liver and kidneys

A Novel Liquid Chromatography–Tandem Mass Spectrometry Method to Quantify Tryptophan and Its Major Metabolites in Serum to Support Biomarker Studies in Patients with Cancer Undergoing Immunotherapy

New approach to rifampicin stability and first-line anti-tubercular drug pharmacokinetics by UPLC-MS/MS

Low on-treatment levels of serum soluble CD8 (sCD8) predict better outcomes in advanced non-small cell lung cancer patients treated with atezolizumab

Low on-treatment levels of serum soluble CD8 (sCD8) predict better outcomes in advanced non-small cell lung cancer patients treated with atezolizumab

Serum sCD25 Protein as a Predictor of Lack of Long-Term Benefits from Immunotherapy in Non-Small Cell Lung Cancer: A Pilot Study

Collaborators (4)

Luigi Brunetti

Anna Siemiątkowska

Marta Karaźniewicz-Łada

Franciszek Główka

Make your next move.